Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study

Schizophrenia (SCZ) acts as a complex and burdensome disease, in which the functional outcome can be validly predicted by cognitive impairment, as one of the core features. However, there still lack considerable markers of cognitive deficits in SCZ. Based on metabolomics, it is expected to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yihe, Sun, Xiujia, Hu, Miaowen, Zhang, Lei, Zhao, Nan, Shen, Yifeng, Yu, Shunying, Huang, Jingjing, Li, Huafang, Yu, Wenjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554540/
https://www.ncbi.nlm.nih.gov/pubmed/36245866
http://dx.doi.org/10.3389/fpsyt.2022.950602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554540/
https://www.ncbi.nlm.nih.gov/pubmed/36245866
http://dx.doi.org/10.3389/fpsyt.2022.950602

Ejemplares similares